2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor TreatmentHemic and Lymphatic Diseases, Myeloproliferative Disorders, blood platelet disease, bone marrow disorder, hematologic disorder, polycythemia, primary myelofibrosis, thrombocytosis diseaseActive, not recruitingPhase 32026-07-08NCT04576156
Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStarsNeoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, angiosarcoma, neoplasm, sarcoma, vascular cancerRecruitingNot stated2025-11-20NCT06375941